Cargando…

Pharmacoeconomics in Africa: needs, prospect and challenges

Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die from preventable and curable diseases. Population increases have led to an increase in dema...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Ajepe, Temitope, Nwogu, Ifechukwu Benedict, Olaoye, Damilola Quazeem, Mustapha, Abdulhafeez Ayodele, Uwizeyimana, Theogene, Adebisi, Yusuff Adebayo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166127/
https://www.ncbi.nlm.nih.gov/pubmed/34059103
http://dx.doi.org/10.1186/s40545-021-00328-5
_version_ 1783701448731656192
author Ben-Ajepe, Temitope
Nwogu, Ifechukwu Benedict
Olaoye, Damilola Quazeem
Mustapha, Abdulhafeez Ayodele
Uwizeyimana, Theogene
Adebisi, Yusuff Adebayo
author_facet Ben-Ajepe, Temitope
Nwogu, Ifechukwu Benedict
Olaoye, Damilola Quazeem
Mustapha, Abdulhafeez Ayodele
Uwizeyimana, Theogene
Adebisi, Yusuff Adebayo
author_sort Ben-Ajepe, Temitope
collection PubMed
description Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die from preventable and curable diseases. Population increases have led to an increase in demands for healthcare, which unfortunately have been met with inequitable distribution of drugs. Hence, the outcomes from healthcare interventions are frequently not maximized. These problems notably call for some economic principles and policies to guide medication selection, procurement, or donation for population prioritization or health insurance. Pharmacoeconomics drives efficient use of scarce or limited resources to maximize healthcare benefits and reduce costs. It also brings to play tools that rate therapy choice based on the quality of life added to the patient after a choice of intervention was made over an alternative. In this paper, we commented on the needs, prospect, and challenges of pharmacoeconomics in Africa.
format Online
Article
Text
id pubmed-8166127
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81661272021-06-02 Pharmacoeconomics in Africa: needs, prospect and challenges Ben-Ajepe, Temitope Nwogu, Ifechukwu Benedict Olaoye, Damilola Quazeem Mustapha, Abdulhafeez Ayodele Uwizeyimana, Theogene Adebisi, Yusuff Adebayo J Pharm Policy Pract Commentary Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die from preventable and curable diseases. Population increases have led to an increase in demands for healthcare, which unfortunately have been met with inequitable distribution of drugs. Hence, the outcomes from healthcare interventions are frequently not maximized. These problems notably call for some economic principles and policies to guide medication selection, procurement, or donation for population prioritization or health insurance. Pharmacoeconomics drives efficient use of scarce or limited resources to maximize healthcare benefits and reduce costs. It also brings to play tools that rate therapy choice based on the quality of life added to the patient after a choice of intervention was made over an alternative. In this paper, we commented on the needs, prospect, and challenges of pharmacoeconomics in Africa. BioMed Central 2021-05-31 /pmc/articles/PMC8166127/ /pubmed/34059103 http://dx.doi.org/10.1186/s40545-021-00328-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Ben-Ajepe, Temitope
Nwogu, Ifechukwu Benedict
Olaoye, Damilola Quazeem
Mustapha, Abdulhafeez Ayodele
Uwizeyimana, Theogene
Adebisi, Yusuff Adebayo
Pharmacoeconomics in Africa: needs, prospect and challenges
title Pharmacoeconomics in Africa: needs, prospect and challenges
title_full Pharmacoeconomics in Africa: needs, prospect and challenges
title_fullStr Pharmacoeconomics in Africa: needs, prospect and challenges
title_full_unstemmed Pharmacoeconomics in Africa: needs, prospect and challenges
title_short Pharmacoeconomics in Africa: needs, prospect and challenges
title_sort pharmacoeconomics in africa: needs, prospect and challenges
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166127/
https://www.ncbi.nlm.nih.gov/pubmed/34059103
http://dx.doi.org/10.1186/s40545-021-00328-5
work_keys_str_mv AT benajepetemitope pharmacoeconomicsinafricaneedsprospectandchallenges
AT nwoguifechukwubenedict pharmacoeconomicsinafricaneedsprospectandchallenges
AT olaoyedamilolaquazeem pharmacoeconomicsinafricaneedsprospectandchallenges
AT mustaphaabdulhafeezayodele pharmacoeconomicsinafricaneedsprospectandchallenges
AT uwizeyimanatheogene pharmacoeconomicsinafricaneedsprospectandchallenges
AT adebisiyusuffadebayo pharmacoeconomicsinafricaneedsprospectandchallenges